SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is seeing significant investor attention driven by upcoming Phase 3 clinical data readouts expected later this year, alongside heightened interest in the psychedelic sector following recent regulatory developments. While many in the community remain bullish on the potential for a major market re-rate, active discussions are focused on the company's substantial cash burn rate, persistent dilution concerns, and the lack of open-market insider buying.

Genius Sports Ltd. engages in the provision of scalable, technology-led products and services to the sports, sports betting, and sports media industries. It also involves in Sports League, which offers technology infrastructure for the collection, integration, and distribution of live data; Sportsbooks, which includes collection of live sports data, odds making, risk management and player marketing; and Sports Media, which provides a range of online marketing and fan engagement tools. The company was founded by Mark Adrian Locke in 2000 and is headquartered in London, United Kingdom.

Genius Sports Limited

Genius Sports is gaining significant community attention as shareholders focus on its critical role as infrastructure for the expanding prediction markets sector and its strategic pivot toward high-growth advertising and fan engagement. Investors are particularly bullish on the companys ability to monetize official data and fan insights, viewing the current stock price as undervalued despite broader market volatility and regulatory discussions.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is gaining momentum as investors rotate into Japanese blockchain and IoT-focused projects, fueling renewed speculation about the token's role in the evolving data-economy ecosystem. The community is actively discussing technical breakouts and long-term utility potential, with sentiment shifting toward bullish as trading volume shows a notable increase.

Oatly Group AB is a holding company, which focuses on developing expertise around oats, a global power crop with inherent properties suited for sustainability and human health. It operates through the following geographical segments: Europe & International, North America and Greater China. The company was founded by Björn Öste in 1994 and is headquartered in Malmö, Sweden.

Oatly Group AB - ADR

Oatly Group

Oatly is trending as investors monitor ongoing strategic reviews, including a potential China carve-out that could improve the balance sheet and reduce debt exposure. The community is actively discussing product expansion into new markets and retail channels like Costco, while also debating the stock's volatility and the impact of its current low market capitalization.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid intense community debate over leaked details of a potential ceasefire agreement with Iran and ongoing skepticism regarding the company's valuation. Traders are actively discussing the impact of these geopolitical negotiations and high-profile company events on the stock's long-term market performance.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is currently trending as investors weigh strong quarterly growth and record backlogs against a large shelf offering that has created short-term supply overhang concerns. Community members are heavily debating the valuation of the space sector ahead of the SpaceX IPO, with many viewing the recent volatility as a buying opportunity for long-term data and analytics exposure.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

Semiconductor stocks remain the central focus of market conversation as investors weigh explosive AI-driven growth against technical exhaustion and concerns about crowded positioning. Community debate remains split between those riding the massive momentum in chip ETFs and skeptics warning that the current pace of capital expenditure in AI infrastructure is reaching a speculative bubble peak.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is trending as investors aggressively pivot toward networking and infrastructure stocks that serve as the backbone for AI data center expansion. The community is actively debating whether this momentum represents a sustainable rerating of a legacy tech giant or a signal of an overextended market cycle reminiscent of past technology bubbles.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

FNMA is trending due to heightened speculation regarding a potential IPO and end to conservatorship following recent comments from President Trump, who suggested the entities could hold a valuation in the trillions. The community remains deeply divided between long-term investors banking on a massive valuation unlock and skeptics who view the repeated news cycles as manipulation intended to create volatility.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently drawing significant attention as investors react to positive Phase 3 results for its CRISPR-based HAE therapy and a subsequent public stock offering. The community is actively debating the impact of the dilution versus the company's strengthened long-term balance sheet, while many remain focused on the potential for a short squeeze given the high short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Stevanato Group S.p.A. (STVN) A Good Stock To Buy Now?

Is Stevanato Group S.p.A. (STVN) A Good Stock To Buy Now...

Stevanato Group Introduces Deora, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences industries, today introduced Deora, a new proprietary pen injector platform targeting incretin-based therapies, as...

Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders Meeting

Stevanato Group S.p.A. (NYSE: STVN) (the Company), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced that all resolutions proposed to the shareholders at the Ordinary and...

Implied Volatility Surging for Stevanato Stock Options

Investors need to pay close attention to STVN stock based on the movements in the options market lately.

Stevanato Group (STVN) Q1 Earnings and Revenues Beat Estimates

Stevanato (STVN) delivered earnings and revenue surprises of +6.56% and +2.32%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today...

Madrigal (MDGL) Reports Q1 Loss, Beats Revenue Estimates

Madrigal (MDGL) delivered earnings and revenue surprises of +9.97% and +3.38%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Stevanato Group to Participate in Three Upcoming Investor Conferences

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in three upcoming investor conferences: Tuesday, May 12, at 8:00...

Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out for

Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stevanato Group S.p.A. (NYSE:STVN) Given Average Recommendation of "Hold" by Brokerages

Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) have been assigned an average rating of "Hold" from the five ratings firms that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a...

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.

Current Price	$17.08
Prev Close	$17.29
Open	$17.40
Dividend Yield	0.31%
50-Day Moving Average	$16.86
Beta	0.85
Avg. Volume	416,217.49
PE Ratio	28.43

52-Week High	$28.00
52-Week Low	$12.89
Market Capitalization	$4.66B
EPS (Annual)	$0.5782
Price to Book	2.64
Revenue Per Employee	N/A

STVNStevanato Group Spa

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest STVN News